Final - October 20, 2011 

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) 

Centers for Disease Control and Prevention
 

1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Atlanta, Georgia
 

October 25-26, 2011 

AGENDA ITEM
 

Tuesday, October 25, 2011
 

8:00 Welcome & Introductions 

8:30 Human Papillomavirus Vaccine 

· Introduction 

· Post licensure safety studies 

· Manufacturer safety study 

· Background Information – HPV vaccine for males 

· GRADE (Grading of Evidence) and proposed recommendation 

for males 

10:30 Break

11:00 · Proposed catch-up recommendation for males 

· VFC vote 

11:30 

· Introduction 

Child/Adolescent Immunization Schedule 

· 2012 immunization schedule 0-18 years of age 

12:00 

· 2012 adult immunization schedule 

Adult Immunization Schedule 

· Introduction 

12:30 Lunch

1:45 

· HBV risk among adults with diabetes 

· Introduction 

· Implementation/vaccine coverage 

· Summary of considerations 

· GRADE (grading of evidence) 

Hepatitis B Vaccine 

· Proposed recommendations 

· Assisted blood glucose monitoring 

3:45 Break

4:00 

· Introduction 

· Cost effectiveness considerations for meningococcal vaccines in 

infants 

Meningococcal Vaccines 

· Epidemiology of meningococcal disease in infants 

· Considerations for use of meningococcal vaccines in infants 

5:30 Public Engagement 

· Summary of public engagement for meningococcal vaccines in 

infants 

5:45 Public Comment 

6:00 Adjourn 

PURPOSE 

Information &
 

Discussion
 

Vote
 

Vote
 

VFC Vote
 

Vote 

Vote 

Information &
 

Discussion
 

Vote
 

Information &
 

Discussion
 

Information &
 

Discussion
 

PRESIDER/PRESENTER(s) 

Dr. Carol Baker (ACIP Chair)
 

Dr. Larry Pickering (ACIP Executive Secretary; CDC)
 

Dr. Joe Bocchini (ACIP, WG Chair) 

Ms. Julianne Gee (CDC/NCEZID)
 

Dr. Christine Velicer, Merck
 

Dr. Lauri Markowitz (CDC/NCHHSTP)
 

Dr. Eileen Dunne (CDC/NCHHSTP)
 

Dr. Eileen Dunne (CDC/NCHHSTP)
 

Dr. Jeanne Santoli (CDC/NCIRD)
 

Dr. Cody Meissner (ACIP, WG Chair)
 

Dr. Iyabode Beysolow (CDC/NCIRD)
 

Ms. Kris Ehresmann (ACIP, WG Chair)
 

Dr. Carolyn B. Bridges (CDC/NCIRD)
 

Dr. Mark Sawyer (ACIP, WG Chair)
 

Dr. Sarah Schillie (CDC/NCHHSTP)
 

Dr. Trudy Murphy (CDC/NCHHSTP)
 

Dr. Pamela Allweiss (CDC/NCCDPHP)
 

Dr. Kathy Byrd (CDC/NCHHSTP)
 

Dr. Sarah Schillie (CDC/NCHHSTP)
 

Dr. Trudy Murphy (CDC/NCHHSTP)
 

Dr. Amanda Cohn (CDC/NCIRD)
 

Ms. Jessica MacNeil (CDC/NCIRD)
 

Dr. Ismael Ortega-Sanchez (CDC/NCIRD)
 

Dr. Amanda Cohn (CDC/NCIRD)
 

Dr.Glen Nowak (CDC/NCIRD)
 

page 1 of 2 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Final - October 20, 2011 

Wednesday, October 26, 2011 

8:00 Unfinished Business 

8:15 

CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NVPO, NIH 

Agency Updates 

8:30 13-valent Pneumococcal Conjugate Vaccine (PCV13) 

· Introduction 

· Immunogenicity of PCV13 in adults: results of phase III studies 

· Considerations for PCV13 use among adults with 

immunocompromising conditions: summary of immunogenicity 

and efficacy studies 

9:30 General Recommendations/Febrile Seizures 

· Update on febrile seizures and vaccines 

9:40 Pertussis 

· Update: pertussis vaccines workgroup activities 

· Update: FDA expanded age indication for Tdap (Boostrix) 

9:50 Immunization coverage of children/adolescents 

10:00 Vaccine Supply 

10:10 Break

10:30 Measles 

· Introduction 

· Epidemiology of measles in the United States 

· Measles outbreak in Canada 

· Measles prevention activities in Mexico 

· Measles vaccination among children with HIV infection 

· Summary of options 

12:15 Influenza 

· Introduction 

· Influenza activity update 

· Vaccine effectiveness 

· Fluzone high-dose safety update 

· Influenza vaccine distribution and coverage 

Information
 

Information &
 

Discussion
 

Information &
 

Discussion
 

Information
 

Information
 

Information
 

Information
 

&
 

Discussion
 

Information
 

&
 

Discussion
 

1:00 Public Comment 

1:15 Adjourn 

GRADE

NACI 

NCCDPHP 

NCEZID 

NCHHSTP 

NCIRD 

NICCHP 

TBD 

Tdap 

WG 

Acronyms

Grading of Recommendations Assessment, Development and Evaluation 

National Advisory Committee on Immunization, Canada 

National Center for Chronic Disease Prevention and Health Promotion 

National Center for Emerging and Zoonotic Infectious Diseases 

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 

National Center for Immunization and Respiratory Diseases 

National Immunization Council and Child Health Program, Mexico 

To be determined 

Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 

Work Group 

Dr. Carol Baker (Chair, ACIP) 

Ex officio members 

Dr. Mike Marcy (ACIP, WG Chair)
 

Dr. Peter Paradiso (Pfizer)
 

Dr. Kathleen Dooling (CDC/NCIRD)
 

Dr. Jeff Duchin (ACIP, WG Chair)
 

Dr. Andrew Kroger (CDC/NCIRD)
 

Dr. Mark Sawyer (ACIP, WG Chair)
 

Dr. Mark Sawyer (ACIP, WG Chair)
 

Dr. Lance Rodewald (CDC/NCIRD)
 

Dr. Jeanne Santoli (CDC/NCIRD)
 

Dr. Jon Temte (ACIP, WG Chair)
 

Dr. Huong McLean (CDC/NCIRD)
 

Dr. Gaston de Serres (Institut national de santé
 

publique du Québec)
 

Dr. Vesta Richardson (ACIP, NICCHP)
 

Dr. George Siberry (NIH)
 

Dr. Huong McLean (CDC/NCIRD)
 

Dr. Wendy Keitel (ACIP, WG Chair)
 

Dr. Lisa Grohskopf (CDC/NCIRD)
 

Dr. Mark Thompson (CDC/NCIRD)
 

Dr. Pedro Moro (CDC/NCIRD)
 

Dr. James Singleton (CDC/NCIRD)
 

page 2 of 2